ZA931516B - Substituted phenylquinazoline derivatives - Google Patents
Substituted phenylquinazoline derivativesInfo
- Publication number
- ZA931516B ZA931516B ZA931516A ZA931516A ZA931516B ZA 931516 B ZA931516 B ZA 931516B ZA 931516 A ZA931516 A ZA 931516A ZA 931516 A ZA931516 A ZA 931516A ZA 931516 B ZA931516 B ZA 931516B
- Authority
- ZA
- South Africa
- Prior art keywords
- substituted
- phenylquinazoline
- derivatives
- phenylquinazoline derivatives
- substituted phenylquinazoline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84512392A | 1992-03-03 | 1992-03-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA931516B true ZA931516B (en) | 1994-09-03 |
Family
ID=25294463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA931516A ZA931516B (en) | 1992-03-03 | 1993-03-03 | Substituted phenylquinazoline derivatives |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0564397A1 (en) |
JP (1) | JPH0649076A (en) |
KR (1) | KR930019642A (en) |
CN (1) | CN1076445A (en) |
AU (1) | AU3387593A (en) |
CA (1) | CA2090635A1 (en) |
CZ (1) | CZ30293A3 (en) |
FI (1) | FI930922A (en) |
HU (1) | HUT63629A (en) |
IL (1) | IL104892A0 (en) |
NO (1) | NO930739L (en) |
NZ (1) | NZ247032A (en) |
TW (1) | TW227563B (en) |
ZA (1) | ZA931516B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1655289A1 (en) * | 2004-11-04 | 2006-05-10 | Embl | Quinazoline derivatives, process for their preparation, their use as antimitotics and pharmaceutical compositions comprising said derivatives |
CN103562198B (en) * | 2011-06-10 | 2016-08-24 | 奇斯药制品公司 | There is muscarinic receptor antagonist and the compound of beta 2-adrenergic receptor agonists activity |
CN104119231A (en) * | 2013-04-27 | 2014-10-29 | 重庆华邦制药有限公司 | Preparation method and intermediate of benzhydrylamine compound |
WO2015120059A1 (en) * | 2014-02-04 | 2015-08-13 | Yates Charles Ryan | Inhibitors of paxillin function and related compositions and methods |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1242863A (en) * | 1968-05-10 | 1971-08-18 | Pharmacia As | 2,3-DIHYDRO-5H-THIAZOLO[2,3-b]QUINAZOLINES AND PROCESSES FOR THE PREPARATION THEREOF |
DE3734909A1 (en) * | 1987-10-15 | 1989-04-27 | Boehringer Ingelheim Kg | USE OF OXOCHINAZOLINE DERIVATIVES IN THE TREATMENT OF HYPERLIPIDAEMIA |
-
1993
- 1993-02-26 EP EP93810142A patent/EP0564397A1/en not_active Withdrawn
- 1993-02-26 HU HU9300556A patent/HUT63629A/en unknown
- 1993-03-01 AU AU33875/93A patent/AU3387593A/en not_active Abandoned
- 1993-03-01 CZ CZ93302A patent/CZ30293A3/en unknown
- 1993-03-01 NZ NZ247032A patent/NZ247032A/en unknown
- 1993-03-01 IL IL104892A patent/IL104892A0/en unknown
- 1993-03-01 CA CA002090635A patent/CA2090635A1/en not_active Abandoned
- 1993-03-01 JP JP5062508A patent/JPH0649076A/en active Pending
- 1993-03-01 NO NO93930739A patent/NO930739L/en unknown
- 1993-03-02 CN CN93102010A patent/CN1076445A/en active Pending
- 1993-03-02 KR KR1019930002998A patent/KR930019642A/en not_active Application Discontinuation
- 1993-03-02 FI FI930922A patent/FI930922A/en not_active Application Discontinuation
- 1993-03-03 ZA ZA931516A patent/ZA931516B/en unknown
- 1993-03-04 TW TW082101580A patent/TW227563B/zh active
Also Published As
Publication number | Publication date |
---|---|
TW227563B (en) | 1994-08-01 |
NO930739D0 (en) | 1993-03-01 |
CZ30293A3 (en) | 1993-12-15 |
HUT63629A (en) | 1993-09-28 |
NZ247032A (en) | 1994-11-25 |
KR930019642A (en) | 1993-10-18 |
HU9300556D0 (en) | 1993-05-28 |
EP0564397A1 (en) | 1993-10-06 |
IL104892A0 (en) | 1993-07-08 |
CN1076445A (en) | 1993-09-22 |
AU3387593A (en) | 1993-09-09 |
FI930922A0 (en) | 1993-03-02 |
CA2090635A1 (en) | 1993-09-04 |
FI930922A (en) | 1993-09-04 |
NO930739L (en) | 1993-09-06 |
JPH0649076A (en) | 1994-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL307812A1 (en) | Substituted thiazolydinone derivatives | |
GR3023621T3 (en) | 3-Hydroxy-4-aryl-5-oxo-pyrazolin derivatives | |
HU9203994D0 (en) | Imidazo-pyridine derivatives | |
LTIP1874A (en) | Substituted azolone derivatives | |
GB9305306D0 (en) | Pyrrolo-pyridazione derivatives | |
HU9301955D0 (en) | Benzophenone-hydrazone derivatives | |
HU9202768D0 (en) | Cyano-phenyl-pyrrole derivatives | |
ZA931876B (en) | 2-Oxoquinoline derivatives | |
HU9202388D0 (en) | Aryl-alkyl-amine derivatives | |
ZA92278B (en) | 3-quinuclidine derivatives | |
ZA922976B (en) | 4-Aryl-3-heteroarylureidoquinoline derivatives | |
EP0520435A3 (en) | Dc-89 derivatives | |
HU9301112D0 (en) | Propenoyl-imidazole derivatives | |
HU9301616D0 (en) | New thio-semicarbazone derivatives | |
GB2271564B (en) | Thioalkylthio carbacephalosporin derivatives | |
GB2270913B (en) | Chlordifluoromethoxyphenyl derivatives | |
ZA931516B (en) | Substituted phenylquinazoline derivatives | |
GB2262739B (en) | Benzofuranylimidazole derivatives | |
GB9102423D0 (en) | Pryimidinyl-and triazinylsalicyl-and-picolinylaldehyde derivatives | |
EP0565961A3 (en) | Ethyl-triazolyl derivatives | |
HU9302058D0 (en) | Thia-diazinone derivatives | |
GB9223244D0 (en) | Phenylpyrazine derivatives | |
ZA934972B (en) | 21-Chloro-pregnane derivative | |
HU9200105D0 (en) | Bipiridyl derivatives | |
HU9301696D0 (en) | Pyrimidofuroxane derivatives |